Archive | May, 2011

A long-term care crisis is brewing around the world: who will provide and pay for LTC?

By 2050, the demand for long-term care (LTC) workers will more than double in the developed world, from Norway and New Zealand to Japan and the U.S. Aging populations with growing incidence of disabilities, looser family ties, and more women in the labor force are driving this reality. This is a multi-dimensional problem which requires [...]

Read full story Comments { 1 }

Most Americans like the idea “Big Government” when it comes to food safety

Two-thirds of Americans favor increasing funding to the Food & Drug Administration (FDA) to ensure food safety in the U.S. Furthermore, 9 in 10 Americans also believe that the Federal government should be responsible for ensuring that food is safe to eat. And, 3 in 4 Americans say if it costs 1 to 3% more money to [...]

Read full story Comments { 0 }

Patients feel out of the Rx drug development process: why participatory health in pharma is important

“Value” in prescription drugs is first and foremost about outcomes, in the eyes of physicians and biopharma. For managed care, “value” is first about safety, then patient outcomes. However, although one-third of patients managing a chronic condition cannot define ”value” in health care, 9 in 10 say that prescription drugs are “valuable” to their health and wellbeing. In [...]

Read full story Comments { 0 }

Health care where we live, play, work and pray: how Ford & Toyota’s mhealth pilots fit into Whole Health

In an interview in March 2011 with the Los Angeles Times, Dr. Regina Benjamin, the U.S. Surgeon General, said, “We can’t look at health in isolation. It’s not just in the doctor’s office. It’s got to be where we live, we work, we play, we pray. If you have a healthy community, you have a healthy [...]

Read full story Comments { 2 }

Don’t assume generics will stop drug cost trends in 2012 and beyond: specialty drugs will drive growing Rx spending

In the 2011 Medco Drug Trend Report, there’s good news and bad news depending on the lens you wear as a health care stakeholder in the U.S. On the positive side of the ledger, for consumers, payers and health plan sponsors, drug trend in 2010 stayed fairly flat at 3.7% growth. That’s due in major [...]

Read full story Comments { 1 }